Lobe Sciences Invites You to Join Us at the Q2 Virtual Investor Summit

- May 12th, 2021

Lobe Sciences today announced that Philip Young, CEO and Director, will be attending the Q2 Virtual Investor Summit.   About Lobe Sciences Lobe is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to …

Lobe Sciences (CSE: LOBE) today announced that Philip Young, CEO and Director, will be attending the Q2 Virtual Investor Summit.

 Event  Q2 Investor Summit
 Date  May 17-18th, 2021
 Presentation  May 18th at 10:15 AM ET
 Location  https://zoom.us/webinar/register/WN_9O2Bo2GAS-Ks6W5cFJKFWQ

 

About Lobe Sciences

Lobe is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.

For further information:

Lobe Sciences
Philip Young CEO & Director
(949) 505-5623
info@lobesciences.com

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.

To request complimentary investor registration: please visit our website at www.investorsummitgroup.com.

Contact:

Sasha Murray at sasha@investorsummitgroup.com

News Provided by Newsfile via QuoteMedia

Get the latest Cannabis Investing stock information

Get the latest information about companies associated with Cannabis Investing Delivered directly to your inbox.

Cannabis Investing

Select None
Select All

Tags

Leave a Reply